Efficacy and safety of weekend cyclosporine treatment as maintenance therapy for preventing frequent disease exacerbations in moderate to severe chronic plaque psoriasis patients – A retrospective cohort study

Abstract

Background: Psoriasis is a chronic, inflammatory, systemic disease with predominant manifestations in the skin and joints impairing patient’s quality of life. A proportion of patients have frequent severe disease exacerbations requiring repeated systemic treatments. There is a scarcity of literature evaluating the role of systemic maintenance therapy in psoriasis patients in preventing such frequent disease flares. Objective: To evaluate the efficacy and safety of weekend cyclosporine treatment (WCT) as maintenance therapy in moderate to severe chronic plaque psoriasis patients for the prevention of frequent disease exacerbations. Methods: In this retrospective cohort study, 22 psoriasis patients with a history of frequent disease exacerbations (≥ 3 in the last 1 year) who were administered WCT (group A) were compared with the same number of matched patients (age and gender) not on WCT or any systemic maintenance therapy (group B). Results: Four patients (18.2%) in group A had disease exacerbations which was significantly lower (p = 0.00, Fisher’s exact test) as compared to 21 patients (95.5%) in group B during the study period. Also, patients in group A had significantly lower number of overall exacerbations [mean ± SD: 0.23 ± 0.53 vs 2.95 ± 1.43) p = 0.00, Mann–Whitney U test] as compared to group B. Four (9.1%) patients in group A encountered adverse effects (acneiform eruptions – two, mild gingival hyperplasia – one, myalgia – one) as compared to three (acneiform eruptions – two, headache – one) in group B (p = 1.00). Conclusion: WCT significantly reduced the number of disease exacerbations and is a safe and effective mode of maintenance therapy in such subset of psoriasis patients.